HIM
ZYME icon

Hillsdale Investment Management’s Zymeworks ZYME Stock Holding History

Hillsdale Investment Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.65M Buy
345,622
+107,700
+45% +$2.55M 0.24% 77
2025
Q4 		$6.26M Buy
237,922
+21,500
+10% +$469K 0.17% 152
2025
Q3 		$3.7M Buy
216,422
+11,400
+6% +$163K 0.11% 249
2025
Q2 		$2.57M Sell
205,022
-31,903
-13% -$380K 0.1% 255
2025
Q1 		$2.82M Buy
236,925
+6,900
+3% +$94.1K 0.14% 187
2024
Q4 		$3.37M Buy
+230,025
New +$3.22M 0.17% 169

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hillsdale Investment Management's ZYME Position: Q1 2026 in Review

Hillsdale Investment Management increased its Zymeworks (ZYME) stake by 45% in Q1 2026, buying an estimated $2.55M and bringing the position to 345,622 shares worth $8.65M. The position accounts for 0.24% of the portfolio, ranked #77.

Hillsdale Investment Management first reported a position in ZYME in Q4 2024 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Hillsdale Investment Management held 345,622 shares of Zymeworks worth $8.65M as of Q1 2026.
  • Hillsdale Investment Management bought 107,700 Zymeworks shares in Q1 2026, an estimated $2.55M.
  • Zymeworks made up 0.24% of Hillsdale Investment Management's portfolio in Q1 2026, its #77 holding.
  • Hillsdale Investment Management first reported a position in Zymeworks in Q4 2024 and has held it in 6 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.